These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 32376155)

  • 21. Vitamin D and axonal injury in multiple sclerosis.
    Sandberg L; Biström M; Salzer J; Vågberg M; Svenningsson A; Sundström P
    Mult Scler; 2016 Jul; 22(8):1027-31. PubMed ID: 26462862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis.
    Gaetani L; Salvadori N; Lisetti V; Eusebi P; Mancini A; Gentili L; Borrelli A; Portaccio E; Sarchielli P; Blennow K; Zetterberg H; Parnetti L; Calabresi P; Di Filippo M
    J Neurol; 2019 Sep; 266(9):2157-2163. PubMed ID: 31129709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dimethyl fumarate decreases neurofilament light chain in CSF and blood of treatment naïve relapsing MS patients.
    Sejbaek T; Nielsen HH; Penner N; Plavina T; Mendoza JP; Martin NA; Elkjaer ML; Ravnborg MH; Illes Z
    J Neurol Neurosurg Psychiatry; 2019 Dec; 90(12):1324-1330. PubMed ID: 31611264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Confounding effect of blood volume and body mass index on blood neurofilament light chain levels.
    Manouchehrinia A; Piehl F; Hillert J; Kuhle J; Alfredsson L; Olsson T; Kockum I
    Ann Clin Transl Neurol; 2020 Jan; 7(1):139-143. PubMed ID: 31893563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autophagy and mitophagy elements are increased in body fluids of multiple sclerosis-affected individuals.
    Patergnani S; Castellazzi M; Bonora M; Marchi S; Casetta I; Pugliatti M; Giorgi C; Granieri E; Pinton P
    J Neurol Neurosurg Psychiatry; 2018 Apr; 89(4):439-441. PubMed ID: 28866627
    [No Abstract]   [Full Text] [Related]  

  • 26. Value contribution of blood-based neurofilament light chain as a biomarker in multiple sclerosis using multi-criteria decision analysis.
    Monreal E; Ruiz PD; San Román IL; Rodríguez-Antigüedad A; Moya-Molina MÁ; Álvarez A; García-Arcelay E; Maurino J; Shepherd J; Cabrera ÁP; Villar LM
    Front Public Health; 2024; 12():1397845. PubMed ID: 38711771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity.
    Högel H; Rissanen E; Barro C; Matilainen M; Nylund M; Kuhle J; Airas L
    Mult Scler; 2020 Feb; 26(2):210-219. PubMed ID: 30570436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High neurofilament levels are associated with clinically definite multiple sclerosis in children and adults with clinically isolated syndrome.
    van der Vuurst de Vries RM; Wong YYM; Mescheriakova JY; van Pelt ED; Runia TF; Jafari N; Siepman TA; Melief MJ; Wierenga-Wolf AF; van Luijn MM; Samijn JP; Neuteboom RF; Hintzen RQ
    Mult Scler; 2019 Jun; 25(7):958-967. PubMed ID: 29774770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis.
    Lycke JN; Karlsson JE; Andersen O; Rosengren LE
    J Neurol Neurosurg Psychiatry; 1998 Mar; 64(3):402-4. PubMed ID: 9527161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolomics detects clinically silent neuroinflammatory lesions earlier than neurofilament-light chain in a focal multiple sclerosis animal model.
    Yeo T; Bayuangga H; Augusto-Oliveira M; Sealey M; Claridge TDW; Tanner R; Leppert D; Palace J; Kuhle J; Probert F; Anthony DC
    J Neuroinflammation; 2022 Oct; 19(1):252. PubMed ID: 36210459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis.
    Mariotto S; Gajofatto A; Zuliani L; Zoccarato M; Gastaldi M; Franciotta D; Cantalupo G; Piardi F; Polo A; Alberti D; Sartori S; Zanusso G; Agrò L; Demurtas R; Sechi G; Sechi E; Monaco S; Ferrari S
    J Neurol; 2019 Jul; 266(7):1643-1648. PubMed ID: 30944980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of neurofilament light chain in the cerebrospinal fluid and blood as a biomarker for neuronal damage in experimental pneumococcal meningitis.
    Le ND; Muri L; Grandgirard D; Kuhle J; Leppert D; Leib SL
    J Neuroinflammation; 2020 Oct; 17(1):293. PubMed ID: 33028339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study.
    Gisslén M; Price RW; Andreasson U; Norgren N; Nilsson S; Hagberg L; Fuchs D; Spudich S; Blennow K; Zetterberg H
    EBioMedicine; 2016 Jan; 3():135-140. PubMed ID: 26870824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishment of neurofilament light chain Simoa assay in cerebrospinal fluid and blood.
    Hendricks R; Baker D; Brumm J; Davancaze T; Harp C; Herman A; Büdingen HV; Townsend M; Fischer SK
    Bioanalysis; 2019 Aug; 11(15):1405-1418. PubMed ID: 31401845
    [No Abstract]   [Full Text] [Related]  

  • 35. Elevated neurofilament light chain CSF/serum ratio indicates impaired CSF outflow in idiopathic intracranial hypertension.
    Engel S; Halcour J; Ellwardt E; Uphaus T; Steffen F; Zipp F; Bittner S; Luessi F
    Fluids Barriers CNS; 2023 Jan; 20(1):3. PubMed ID: 36631830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation.
    Gaetani L; Höglund K; Parnetti L; Pujol-Calderon F; Becker B; Eusebi P; Sarchielli P; Calabresi P; Di Filippo M; Zetterberg H; Blennow K
    Alzheimers Res Ther; 2018 Jan; 10(1):8. PubMed ID: 29370869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and MRI correlates of CSF neurofilament light chain levels in relapsing and progressive MS.
    Damasceno A; Dias-Carneiro RPC; Moraes AS; Boldrini VO; Quintiliano RPS; da Silva VAPG; Farias AS; Brandão CO; Damasceno BP; Dos Santos LMB; Cendes F
    Mult Scler Relat Disord; 2019 May; 30():149-153. PubMed ID: 30772673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autophagy and mitophagy biomarkers are reduced in sera of patients with Alzheimer's disease and mild cognitive impairment.
    Castellazzi M; Patergnani S; Donadio M; Giorgi C; Bonora M; Bosi C; Brombo G; Pugliatti M; Seripa D; Zuliani G; Pinton P
    Sci Rep; 2019 Dec; 9(1):20009. PubMed ID: 31882960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing tissue damage in multiple sclerosis: a biomarker approach.
    Burman J; Zetterberg H; Fransson M; Loskog AS; Raininko R; Fagius J
    Acta Neurol Scand; 2014 Aug; 130(2):81-9. PubMed ID: 24571714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship of cerebrospinal fluid neurofilament levels with magnetic resonance imaging lesion location and disease activity in multiple sclerosis.
    Adams A; Tilden W; Bestwick J; Holden D; Bianchi L; Smets I; Giovannoni G; Gnanapavan S
    Eur J Neurol; 2022 Sep; 29(9):2754-2760. PubMed ID: 35615966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.